SignatureFD
LXEO icon

SignatureFD’s Lexeo Therapeutics LXEO Stock Holding History

SignatureFD’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$28.3K Buy
8,362
+8,203
+5,159% +$37.1K ﹤0.01% 2259
2026
Q2 		$740 Sell
159
-41
-21% -$222 ﹤0.01% 3305
2026
Q1 		$1.15K Sell
200
-90
-31% -$638 ﹤0.01% 3179
2025
Q4 		$2.88K Buy
290
+112
+63% +$1.02K ﹤0.01% 2873
2025
Q3 		$1.18K Buy
+178
New +$861 ﹤0.01% 3053

Other funds holding LXEO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

SignatureFD's LXEO Position: Q3 2026 in Review

SignatureFD increased its Lexeo Therapeutics (LXEO) stake by 5,159% in Q3 2026, buying an estimated $37.1K and bringing the position to 8,362 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2259.

SignatureFD first reported a position in LXEO in Q3 2025 and has held it in 5 quarters since. 45 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.

  • SignatureFD held 8,362 shares of Lexeo Therapeutics worth $28.3K as of Q3 2026.
  • SignatureFD bought 8,203 Lexeo Therapeutics shares in Q3 2026, an estimated $37.1K.
  • Lexeo Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2259 holding.
  • SignatureFD first reported a position in Lexeo Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • 45 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.